President Donald Trump is using national security as a justification to implement steep pharmaceutical tariffs on drugs imported from other countries to pressure companies to lower domestic drug prices and boost U.S. production.

Trump signed an executive order on Thursday afternoon imposing 100% tariffs on patented pharmaceutical products and active pharmaceutical ingredients imported from all but five countries as a means to incentivize drugmakers to lower their U.S. prices and onshore their production facilities.